TAG:
genetic test
LIS As Productivity Tool Throughout the Laboratory
By Robert Michel | From the Volume XVI No. 3 – February 19, 2007 Issue
CEO SUMMARY: Is the classic laboratory information system (LIS) morphing into a different information technology product? That’s the observation of one laboratory IT expert, who says that “best of breed” LIS products are becoming productivity tools that support improved clinical per…
Key Trends Drive Change for Clinical Laboratories
By Robert Michel | From the Volume XIV No. 1 – January 8, 2007 Issue
CEO SUMMARY: Technology plays an ever-growing role in reshaping the organization and operation of clinical laboratories. New technologies figure prominently in THE DARK REPORT’S 2007 list of key trends in the clinical laboratory industry. Technological advances in instr…
Pathologist Builds General Path Business From Office Lab
By Robert Michel | From the Volume XIII No. 16 – November 27, 2006 Issue
CEO SUMMARY: Doctors Pathology Services in Delaware is successful for two reasons. First it runs the largest pathology lab in the state. But more important, it runs one of the few successful mobile pathology services anywhere. The Mobile Intraoperative Consultation Service(MICS)allows the…
Bio-Reference Enters DNA Sequencing Market
By Robert Michel | From the Volume XIII No. 12 – September 5, 2006 Issue
CEOSUMMARY: Bio-Reference Laboratories has just placed an unexpected bet on the wide-open opportunities in genetic testing. The acquisition of GeneDX brings it a respected team of geneticists, capabilities in full DNA sequencing, and a proven track record in testing for rare and complex h…
Focus Diagnostics, Inc. To Be Acquired by Quest
CEO SUMMARY: Another national laboratory company loses its independence and consolidation of the lab industry continues. Last Friday it was announced that Quest Diagnostics Incorporated would acquire the laboratory testing and diagnostic…
CYP450 Testing To Have Major Clinical Impact
By Robert Michel | From the Volume XIII No. 5 – April 10, 2006 Issue
CEO SUMMARY: Pharmacogenomics, companion diagnostics, “personalized prescription drug therapy”—by any name, use of molecular diagnostics to guide clinicians in the prescribing and dosing of drugs is about to expand exponentially. Some experts predict that CYP450 testing alone will …
Complete Human DNA Profiling as a STAT Test
By R. Lewis Dark | From the Volume XIII No. 2 – February 6, 2006 Issue
MOST OF YOU ARE UNFAMILIAR WITH A NEW SCIENTIFIC PRIZE that is in the planning stage. On January 27, The Wall Street Journal published a story that disclosed the plans of the X Prize Foundation to award a prize, totaling between $5 million and $20 million, to the team that first deco…
Lab Tests in Pharmacies, Genzyme, Healthe, Singing River Hospital, VA
By Robert Michel | From the Volume XII No. 15 – October 24, 2005 Issue
IT IS OFTEN SUGGESTED that pharmacies are a logical place to combine laboratory testing with prescription services. Such an arrangement would be consumer-friendly and has the potential to improve patient care while lowering costs. In Great Britain, the National Health Service has launched a pilot pr…
Molecular Diagnostics: How Beaumont Built A Successful Program
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: It was about 15 years ago when William Beaumont Hospital and Beaumont Reference Laboratories first began offering molecular diagnostic testing services to clinicians. This successful effort came about because of effective strategic planning, use of consulting expertise at key…
Bi-Annual Look at Trends Reshaping Clinical Labs
By Robert Michel | From the Volume XII No. 2 – January 24, 2005 Issue
CEO SUMMARY: Among other things, we declare the end to the heyday of the independent commercial lab company which offers a broad test menu to all types of office-based physicians. In its place springs forth the specialty or niche testing laboratory. Small and focused on a specific number …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized